Development and characterization of a novel human CD137 agonistic antibody with anti‐tumor activity and a good safety profile in non‐human primates.
- Resource Type
- Article
- Source
- FEBS Open Bio; Dec2022, Vol. 12 Issue 12, p2166-2178, 13p
- Subject
KILLER cells ANTINEOPLASTIC agents MONOCLONAL antibodies REGULATORY T cells MAST cells PRIMATES IMMUNOGLOBULINS - Language
- ISSN
- 22115463